ABHD3
Phospholipase ABHD3
Also known as: ABHD3_HUMAN, LABH3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WU67
- Gene
- ABHD3
- Ensembl
- ENSG00000158201
- Chromosome
- 18
- Canonical length
- 409 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
OverviewNCBI Gene
This gene encodes a protein containing an alpha/beta hydrolase fold, which is a catalytic domain found in a very wide range of enzymes. The function of this protein has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
409 residues, UniProt reviewed canonical sequence.
>Q8WU67|ABHD3
1 MQRLAMDLRM LSRELSLYLE HQVRVGFFGS GVGLSLILGF SVAYAFYYLS SIAKKPQLVT
61 GGESFSRFLQ DHCPVVTETY YPTVWCWEGR GQTLLRPFIT SKPPVQYRNE LIKTADGGQI
121 SLDWFDNDNS TCYMDASTRP TILLLPGLTG TSKESYILHM IHLSEELGYR CVVFNNRGVA
181 GENLLTPRTY CCANTEDLET VIHHVHSLYP SAPFLAAGVS MGGMLLLNYL GKIGSKTPLM
241 AAATFSVGWN TFACSESLEK PLNWLLFNYY LTTCLQSSVN KHRHMFVKQV DMDHVMKAKS
301 IREFDKRFTS VMFGYQTIDD YYTDASPSPR LKSVGIPVLC LNSVDDVFSP SHAIPIETAK
361 QNPNVALVLT SYGGHIGFLE GIWPRQSTYM DRVFKQFVQA MVEHGHELSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- rectum: 62 nTPM
- colon: 60 nTPM
- small intestine: 53 nTPM
- duodenum: 42 nTPM
- liver: 37 nTPM
- stomach: 34 nTPM
Single-cell type
- myonuclei: 655 nCPM
- epididymal clear cells: 519 nCPM
- endometrial luminal cells: 514 nCPM
- neutrophils: 488 nCPM
- pancreatic duct cells: 464 nCPM
- esophageal apical cells: 462 nCPM
Immune cell
- basophil: 90 nTPM
- neutrophil: 82 nTPM
- non-classical monocyte: 62 nTPM
- T-reg: 45 nTPM
- intermediate monocyte: 44 nTPM
- eosinophil: 29 nTPM
Brain region
- choroid plexus: 36 nTPM
- cerebellum: 22 nTPM
- thalamus: 22 nTPM
- pons: 22 nTPM
- midbrain: 21 nTPM
- white matter: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- medium-chain fatty acid biosynthetic process
- medium-chain fatty acid catabolic process
- phosphatidylcholine biosynthetic process
- phosphatidylcholine metabolic process
Molecular functions
- acetylesterase activity
- monoacylglycerol lipase activity
- phospholipase A1 activity
- phospholipase A2 activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD3 as an antibody target. Whether an autoantibody or antibody against ABHD3 could matter depends on whether native ABHD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD3 is annotated at the cell surface, where native ABHD3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ABHD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...